2010 - Libin/AHFMR Prize in Cardiovascular Research
His scientific interests lie mostly in Internal medicine, Cardiology, Atrial fibrillation, Heart rate and Myocardial infarction. His works in Heart disease, Heart failure, Heart rate variability, Risk factor and QT interval are all subjects of inquiry into Internal medicine. His Cardiology study frequently involves adjacent topics like Anesthesia.
His study in Atrial fibrillation is interdisciplinary in nature, drawing from both Stroke and Intensive care medicine. A. John Camm combines subjects such as Clinical trial and MEDLINE with his study of Intensive care medicine. His work deals with themes such as Survival rate, Placebo, Coronary atherosclerosis and Ventricular tachycardia, which intersect with Myocardial infarction.
His primary areas of study are Internal medicine, Cardiology, Atrial fibrillation, Anesthesia and Myocardial infarction. His study in Electrocardiography, Heart disease, Heart rate, Ventricular tachycardia and Heart failure is done as part of Internal medicine. His study deals with a combination of Cardiology and In patient.
A. John Camm has included themes like Stroke, Anticoagulant and Intensive care medicine in his Atrial fibrillation study. His work carried out in the field of Intensive care medicine brings together such families of science as Clinical trial and MEDLINE. His biological study spans a wide range of topics, including Placebo and Flecainide.
Atrial fibrillation, Internal medicine, Cardiology, Stroke and Intensive care medicine are his primary areas of study. His Atrial fibrillation study integrates concerns from other disciplines, such as Anticoagulant and Heart failure. As a member of one scientific family, A. John Camm mostly works in the field of Internal medicine, focusing on Anesthesia and, on occasion, Placebo.
His Cardiology study focuses mostly on Amiodarone, Cardiac arrhythmia, Ablation, Acute coronary syndrome and Left atrial. His Stroke research is multidisciplinary, relying on both Randomized controlled trial, Surgery, Warfarin and Risk factor. His Intensive care medicine research also works with subjects such as
A. John Camm mainly focuses on Atrial fibrillation, Internal medicine, Stroke, Cardiology and Intensive care medicine. The Atrial fibrillation study combines topics in areas such as Prospective cohort study, Randomized controlled trial and Clinical trial. A. John Camm works mostly in the field of Internal medicine, limiting it down to topics relating to Anesthesia and, in certain cases, Placebo, as a part of the same area of interest.
His Stroke research integrates issues from Surgery, Vitamin K antagonist, Warfarin, Apixaban and Edoxaban. A. John Camm is involved in the study of Cardiology that focuses on Cardiac arrhythmia in particular. A. John Camm has included themes like Observational study, Heart failure, Quality of life, Coronary artery disease and Catheter ablation in his Intensive care medicine study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno.
European Journal of Heart Failure (2016)
Heart rate variability. Standards of measurement, physiological interpretation, and clinical use
Marek Malik;J. Thomas Bigger;A. John Camm;Robert E. Kleiger.
European Heart Journal (1996)
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns.
Circulation (2006)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm;Paulus Kirchhof;Irene Savelieva.
European Heart Journal (2010)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association
A. John Camm;Jeroen J. Bax;Robert Fagard.
Europace (2012)
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
Europace (2012)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T Ruff;Robert P Giugliano;Eugene Braunwald;Elaine B Hoffman.
The Lancet (2014)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm;Gregory Y.H. Lip.
European Heart Journal (2012)
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
Journal of Interventional Cardiac Electrophysiology (2012)
Universal definition of myocardial infarction.
Kristian Thygesen;Joseph S. Alpert;Harvey D. White;Allan S. Jaffe.
European Heart Journal (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Imperial College London
University of Birmingham
University of Liverpool
Leipzig University
McMaster University
University of Oslo
Maastricht University Medical Centre
Istituto Auxologico Italiano
Mayo Clinic
University of Pavia
Microsoft (United States)
University of Pecs
Medical Research Council
Soochow University
Spanish National Research Council
Data First COnsulting
Duke University
University of Miami
Monash University
Brown University
Memorial Sloan Kettering Cancer Center
Samsung Medical Center
Maastricht University
University of Reading
University of Montana
University of Wisconsin–Madison